Shire PLC (SHPG) Sees Large Volume Increase
Shire PLC (NASDAQ:SHPG) saw strong trading volume on Friday . 966,248 shares traded hands during mid-day trading, an increase of 25% from the previous session’s volume of 774,547 shares.The stock last traded at $191.92 and had previously closed at $188.50.
A number of equities research analysts have recently commented on the company. Goldman Sachs Group Inc. reissued a “buy” rating on shares of Shire PLC in a research note on Tuesday, June 28th. Zacks Investment Research cut Shire PLC from a “buy” rating to a “hold” rating in a research note on Wednesday, June 8th. Shore Capital reissued a “buy” rating on shares of Shire PLC in a research note on Tuesday, June 14th. Sanford C. Bernstein reissued an “outperform” rating and issued a $222.00 target price on shares of Shire PLC in a research note on Thursday, June 9th. Finally, Leerink Swann reissued a “buy” rating and issued a $213.00 target price (down from $225.00) on shares of Shire PLC in a research note on Thursday, June 16th. Four research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $237.41.
The firm’s 50-day moving average is $195.29 and its 200-day moving average is $180.79. The stock has a market capitalization of $57.30 billion and a price-to-earnings ratio of 39.98.
Shire PLC (NASDAQ:SHPG) last issued its quarterly earnings results on Tuesday, August 2nd. The biopharmaceutical company reported $3.38 EPS for the quarter, topping the Zacks’ consensus estimate of $3.03 by $0.35. The firm had revenue of $2.43 million for the quarter, compared to analyst estimates of $2.28 billion. The business’s revenue was up 55.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.63 EPS. On average, equities analysts expect that Shire PLC will post $12.93 earnings per share for the current fiscal year.
The company also recently declared a dividend, which will be paid on Friday, October 7th. Shareholders of record on Friday, September 9th will be given a dividend of $0.139 per share. The ex-dividend date of this dividend is Wednesday, September 7th.
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.